The Polo-like kinase Plx1 interacts with and inhibits Myt1 after fertilization of Xenopus eggs

被引:64
|
作者
Inoue, D
Sagata, N
机构
[1] Kyushu Univ, Grad Sch Sci, Dept Biol, Fukuoka 8128581, Japan
[2] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan
来源
EMBO JOURNAL | 2005年 / 24卷 / 05期
关键词
cell cycle; fertilization; Myt1; Plk1; p90(rsk);
D O I
10.1038/sj.emboj.7600567
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
During the meiotic cell cycle in Xenopus oocytes, p90(rsk), the downstream kinase of the Mos - MAPK pathway, interacts with and inhibits the Cdc2 inhibitory kinase Myt1. However, p90(rsk) is inactivated after fertilization due to the degradation of Mos. Here we show that the Polo- like kinase Plx1, instead of p90(rsk), interacts with and inhibits Myt1 after fertilization of Xenopus eggs. At the M phase of the embryonic cell cycle, Cdc2 phosphorylates Myt1 on Thr478 and thereby creates a docking site for Plx1. Plx1 can phosphorylate Myt1 and inhibit its kinase activity both in vitro and in vivo. The interaction between Myt1 and Plx1 is required, at least in part, for normal embryonic cell divisions. Finally, and interestingly, Myt1 is phosphorylated on Thr478 even during the meiotic cell cycle, but its interaction with Plx1 is largely inhibited by p90(rsk)-mediated phosphorylation. These results indicate a switchover in the Myt1 inhibition mechanism at fertilization of Xenopus eggs, and strongly suggest that Plx1 acts as a direct inhibitory kinase of Myt1 in the mitotic cell cycles in Xenopus.
引用
收藏
页码:1057 / 1067
页数:11
相关论文
共 50 条
  • [41] Polo-like kinase 1 as a biomarker in rectal cancers
    Lim, Stephanie Hui-Su
    Shin, J-S
    Tut, T. G.
    Ng, W. T. W.
    Chug, Wei
    Dissanayake, I. U.
    Spring, Kevin
    Ng, Weng
    Bokey, Les
    De Souza, Paul
    Lee, C. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [42] Putting a bit into the polo-box domain of polo-like kinase 1
    Park J.-E.
    Kim T.-S.
    Meng L.
    Bang J.K.
    Kim B.Y.
    Lee K.S.
    Journal of Analytical Science and Technology, 6 (1)
  • [43] Identification of Rictor as a Novel Substrate of Polo-like kinase 1
    Shao, Tian
    Liu, Xiaoqi
    CELL CYCLE, 2015, 14 (05) : 755 - 760
  • [44] Polo-Like Kinase 1 in the Life and Death of Cancer Cells
    Liu, Xiaoqi
    Erikson, Raymond L.
    CELL CYCLE, 2003, 2 (05) : 424 - 425
  • [45] ALTERNATIVE TARGETS FOR MEDULLOBLASTOMA TREATMENT: POLO-LIKE KINASE 1
    Pezuk, J. A.
    Manzini, P. M. R.
    Oliveira, J. C. D.
    Morales, A. G.
    Queiroz, R. D. P.
    Scrideli, C. A.
    Valera, E. T.
    Brassesco, M. S.
    Tone, L. G.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 133 - 133
  • [46] Diversity evolution and jump of Polo-like kinase 1 inhibitors
    Liao Chenzhong
    Yao RiSheng
    SCIENCE CHINA-CHEMISTRY, 2013, 56 (10) : 1392 - 1401
  • [47] POLO-LIKE KINASE 1 AS A POTENTIAL TARGET IN PEDIATRIC MEDULLOBLASTOMA
    Pezuk, Julia Alejandra
    Brassesco, Maria Sol
    de Oliveira, Jaqueline Carvalho
    Morales, Andressa Gois
    Queiroz, Rosane
    Scrideli, Carlos Alberto
    Valera, Elvis Tercy
    Tone, Luiz Gonzaga
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1092 - 1092
  • [48] Polo-like kinase 1 is essential to DNA damage recovery
    Liu, Lin
    Zhang, Min
    Zou, Ping
    LEUKEMIA & LYMPHOMA, 2010, 51 (06) : 1079 - 1089
  • [49] Opinion - Targeting polo-like kinase 1 for cancer therapy
    Strebhardt, K
    Ullrich, A
    NATURE REVIEWS CANCER, 2006, 6 (04) : 321 - 330
  • [50] Inhibitors of the polo-like protein kinase Plk-1
    Nixey, Thomas
    Boylan, John
    Hulme, C.
    Powers, David
    Smith, Adrian
    Wong, Andrew
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231